Antimicrobial resistance

Antimicrobial resistance

Red Overlay
Antimicrobial resistance
Antimicrobial resistance
Red Overlay

Now available - Minimizing Risk of Antimicrobial Resistance on-demand training course

Register

Mitigating environmental impact from antibiotic wastewater discharge in the manufacturing environment

What is antimicrobial resistance?

According to the World Health Organization, antimicrobial resistance (AMR) has been declared a top 10 global public health threat and is expected to get worse unless action is taken. Resistance can come from many sources – BSI is working with the pharmaceutical industry to focus on the evolution of responsible manufacturing of antibiotics.

Manufacturing waste from the production of antibiotics can contribute to the development of AMR in the environment unless emissions from waste streams are effectively controlled. It threatens to undermine the basis of modern medicine by rendering the antibiotics used to treat and prevent infections ineffective.

In 2019, AMR bacteria accounted for 1.27 million deaths and contributed to almost another five million deaths during the same year, according to IHME/The Lancet. 

Antimicrobial Resistance training

Minimizing Risk of Antimicrobial Resistance
on-demand course >

Manufacturing waste from the production of antibiotics can contribute to the development of AMR (Anti-Microbial Resistance) in the environment unless emissions from waste streams are effectively controlled. It threatens to undermine the basis of modern medicine by rendering the antibiotics used to treat and prevent infections ineffective.

This course provides the fundamentals of the AMR standard developed by AMRIA and BSI, to help you understand and apply the best practices to get your organization ready for implementation, assessment and certification.

View details for Minimizing Risk of Antimicrobial Resistance
on-demand course >

On-demand eLearning

BSI driving action and progress

Standard:

A person wearing white gloves checking medication on a tableThe AMR Industry Alliance engaged BSI to facilitate the development of a private standard by working with the Alliance and multiple industry stakeholders. A comprehensive industry standard was published in June 2022, for assessing the impact of pharmaceuticals in the environment for the Anti-Microbial Resistance topic, called the Antibiotic Manufacturing Standard.

 

Certification:

The Alliance and BSI are now developing an industry certification scheme, and BSI will serve an assessment body role that will enable antibiotic manufacturers to demonstrate that the wastewater dilution and control requirements of the Antibiotic Manufacturing standard have been satisfied. We are now developing an industry certification scheme with the AMR Industry Alliance which is due to be launched in 2023.


This independent and impartial certification program is perfectly situated to serve as a mechanism for antibiotic manufacturers to show evolving good practice. While government regulators have a role to play in promoting responsible manufacturing, the industry has shown its willingness to self-regulate by developing this manufacturing standard and independent certification scheme.

If you would like to participate in the certification scheme, please contact us:

Get in touch